The molecular genetics of Marfan syndrome and related disorders.

The molecular genetics of Marfan syndrome and related disorders.

Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1). The leading cause of premature death in untreated indiv...

Bibliografske podrobnosti
Main Authors:	Robinson, P, Arteaga-Solis, E, Baldock, C, Collod-Béroud, G, Booms, P, De Paepe, A, Dietz, H, Guo, G, Handford, P, Judge, D, Kielty, C, Loeys, B, Milewicz, D, Ney, A, Ramirez, F, Reinhardt, D, Tiedemann, K, Whiteman, P, Godfrey, M
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

The revised Ghent nosology for the Marfan syndrome.
od: Loeys, B, et al.
Izdano: (2010)

Molecular pathology of the Marfan syndrome
od: Handford, P
Izdano: (1999)

Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders.
od: Whiteman, P, et al.
Izdano: (2003)

Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?
od: Hutchinson, S, et al.
Izdano: (2003)

Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?
od: Hutchinson, S, et al.
Izdano: (2003)

Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice.
od: Halliday, D, et al.
Izdano: (2002)

Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1.
od: Whiteman, P, et al.
Izdano: (2007)

Osteoporosis in Marfan's syndrome
od: Carter, N, et al.
Izdano: (1998)

Molecular effects of calcium binding mutations in Marfan syndrome depend on domain context.
od: McGettrick, A, et al.
Izdano: (2000)

Familial spontaneous pneumothorax is not linked to FBN-1, the defective gene in the Marfan syndrome.
od: Maskell, N, et al.
Izdano: (2000)

Foot pain and disability in Marfan's syndrome
od: Holden, W, et al.
Izdano: (2005)

Bone mineral density in Marfan syndrome - Reply
od: Wordsworth, P
Izdano: (2001)

Marfan syndrome caused by a mutation in FBN1 that gives rise to cryptic splicing and a 33 nucleotide insertion in the coding sequence.
od: Hutchinson, S, et al.
Izdano: (2001)

A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias
od: Jensen, S, et al.
Izdano: (2015)

Molecular effects of homocysteine on cbEGF disulphide bonding: insights into the pathogenesis of homocystinuria and its clinical similarity to Marfan syndrome
od: Hutchinson, S, et al.
Izdano: (2004)

Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.
od: Loeys, B, et al.
Izdano: (2010)

Whole Exome Sequencing is a Sensitive and Cost-Effective Means of Detecting Mutations in Patients with Marfan Syndrome and Osteogenesis Imperfecta
od: Duncan, E, et al.
Izdano: (2013)

Investigation of muscle bioenergetics in the Marfan syndrome indicates reduced metabolic efficiency.
od: Crilley, J, et al.
Izdano: (2007)

Bone mineral density in Marfan syndrome.
od: Le Parc, J, et al.
Izdano: (2001)

The impact of obstructive sleep apnea on aortic disease in Marfan's syndrome.
od: Kohler, M, et al.
Izdano: (2013)

Bone mineral density in adults with Marfan syndrome.
od: Carter, N, et al.
Izdano: (2000)

The impact of obstructive sleep apnea on aortic disease in Marfan's syndrome
od: Kohler, M, et al.
Izdano: (2013)

The prevalence of obstructive sleep apnoea and its association with aortic dilatation in Marfan's syndrome.
od: Kohler, M, et al.
Izdano: (2009)

Fibrillin-1 misfolding and disease.
od: Whiteman, P, et al.
Izdano: (2006)

Segregation of all four major fibrillar collagen genes in the Marfan syndrome.
od: Ogilvie, D, et al.
Izdano: (1987)

Endothelial dysfunction in the Marfan syndrome accelerates phosphocreatine depletion in early exercise: Implications for muscle fatigue in chronic heart failure
od: Crilley, J, et al.
Izdano: (2001)

MLPA-based point mutation analysis of the FBN1 gene in Marfan syndrome patients.
od: Bunyan, D, et al.
Izdano: (2004)

Assessment of carotid compliance using real time vascular ultrasound image analysis in Marfan syndrome
od: Kiotsekoglou, A, et al.
Izdano: (2007)

4D-FLOW CMR DEMONSTRATES THE REGIONAL DISTRIBUTION OF AORTIC FLOW DISTURBANCE IN MARFAN SYNDROME
od: Pitcher, A, et al.
Izdano: (2011)

Cardiovascular manifestations of Marfan syndrome: insights from advanced cardiovascular magnetic resonance
od: Pitcher, A
Izdano: (2012)

Fibrillin: from domain structure to supramolecular assembly.
od: Handford, P, et al.
Izdano: (2000)

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
od: Mullen, M, et al.
Izdano: (2019)

Investigating molecular mechanisms underlying Marfan syndrome, based on fibrillin-1 secretion and assembly
od: Atwa, O
Izdano: (2020)

Non-linear and flexible regions of the human Notch-1 extracellular domain revealed by high-resolution structural studies
od: Redfield, C, et al.
Izdano: (2016)

Dynamic analysis of fibrillin organization and function during avian development
od: Rongish, B, et al.
Izdano: (2004)

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials
od: Pitcher, A, et al.
Izdano: (2022)

A G1127S change in calcium-binding epidermal growth factor-like domain 13 of human fibrillin-1 causes short range conformational effects.
od: Whiteman, P, et al.
Izdano: (2001)

Solution structure and dynamics of a calcium binding epidermal growth factor-like domain pair from the neonatal region of human fibrillin-1.
od: Smallridge, R, et al.
Izdano: (2003)

A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.
od: Mullen, M, et al.
Izdano: (2013)

Achievement Gap between Indigenous and Non-Indigenous Children in Peru: An Analysis of Young Lives Survey Data
od: Arteaga, I, et al.
Izdano: (2014)